SCHEMBL6765717

SCHEMBL6765717

CC(C)(C)[Si](C)(C)Oc1cccc(C(=O)CCN2CCCN(Cc3ccc(S(C)(=O)=O)cc3)CC2)c1

nearest known ligand 0.51

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 19/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6770077 0.80 CCR2 (0.65) CCR2
SCHEMBL8458456 0.72 CCR2 (0.65) CCR2
SCHEMBL6776114 0.72 CCR2 (0.58) CCR2
SCHEMBL9323567 0.71 SIGMAR1 (0.64)
SCHEMBL4000875 0.69 NR4A2 (0.46)
SCHEMBL555801 0.68 GSK3B (0.48)
SCHEMBL2676116 0.68 HSP90AA1 (0.41)
SCHEMBL7227677 0.67 PDE4B (0.46)
SCHEMBL5182076 0.67 CTNNB1 (0.45)
SCHEMBL14957792 0.66 KMT2A (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6686353-B1 PREVENTING BLOOD MONOCYTES AND LYMPHOCYTES FROM INFILTRATING TISSUE TEIJIN INTELLECTUAL PROPERTY CENTER LIMITED (JP) 2004-02-03 US disclosed
EP-0914319-B1 DIARYLALKYL CYCLIC DIAMINE DERIVATIVES AS CHEMOKINE RECEPTOR ANTAGONISTS TEIJIN LTD (JP) 2001-11-21 EP disclosed
EP-0914319-A1 DIARYLALKYL CYCLIC DIAMINE DERIVATIVES AS CHEMOKINE RECEPTOR ANTAGONISTS TEIJIN LIMITED (JP) 1999-05-12 EP disclosed
WO-1997044329-A9 DIARYLALKYL CYCLIC DIAMINE DERIVATIVES AS CHEMOKINE RECEPTOR ANTAGONISTS 1998-03-12 WO disclosed
WO-1997044329-A1 DIARYLALKYL CYCLIC DIAMINE DERIVATIVES AS CHEMOKINE RECEPTOR ANTAGONISTS TEIJIN LIMITED (JP) 1997-11-27 WO disclosed